PRM4 Assessment of Immunosuppressive Therapies for Renal Transplantation - Criteria Considered for Evaluation by the EMA, European HTA Agencies and the German IQWiG
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1468
https://www.valueinhealthjournal.com/article/S1098-3015(12)03181-6/fulltext
Section Title :
Research on Methods
Section Order :
964
First Page :
A460
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03181-6&doi=10.1016/j.jval.2012.08.1468